A further D769N mutation was detected by Tschui et al. in a HER2-amplified tumor, occurring at the same amino acid position than two other mutations (D769H and D769Y) associated with breast cancer, both resulting in the constitutive activation of the enzyme [78]. The gene discussed is ERBB2; the disease is breast carcinoma.